Synopex Toekomstige groei

Future criteriumcontroles 3/6

Synopex zal naar verwachting groeien in winst en omzet met respectievelijk 27.5% en 16.3% per jaar. De winst per aandeel zal naar verwachting groeien met 27.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16.8% zijn.

Belangrijke informatie

27.5%

Groei van de winst

27.4%

Groei van de winst per aandeel

Electronic winstgroei	34.9%
Inkomstengroei	16.3%
Toekomstig rendement op eigen vermogen	16.8%
Dekking van analisten	Low
Laatst bijgewerkt	07 Oct 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Is Now The Time To Look At Buying Synopex Inc. (KOSDAQ:025320)?

Nov 13

Returns At Synopex (KOSDAQ:025320) Are On The Way Up

Oct 24

Risks Still Elevated At These Prices As Synopex Inc. (KOSDAQ:025320) Shares Dive 25%

Aug 26

There's Reason For Concern Over Synopex Inc.'s (KOSDAQ:025320) Massive 26% Price Jump

Jul 01

Market Participants Recognise Synopex Inc.'s (KOSDAQ:025320) Revenues Pushing Shares 55% Higher

Mar 11

Here's Why Synopex (KOSDAQ:025320) Can Afford Some Debt

Feb 16

Synopex (KOSDAQ:025320) Shareholders Have Enjoyed An Impressive 227% Share Price Gain

Dec 25

Winst- en omzetgroeiprognoses

KOSDAQ:A025320 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (KRW Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	365,000	34,600	N/A	N/A	1
12/31/2025	300,000	23,000	N/A	N/A	1
12/31/2024	268,400	19,600	N/A	N/A	1
9/30/2024	251,168	19,288	13,529	43,719	N/A
6/30/2024	259,695	20,806	13,181	39,056	N/A
3/31/2024	255,242	17,306	20,741	45,839	N/A
12/31/2023	262,173	14,601	28,531	48,094	N/A
9/30/2023	254,752	6,165	30,142	44,021	N/A
6/30/2023	241,181	7,915	26,436	40,019	N/A
3/31/2023	251,423	8,796	27,990	38,475	N/A
12/31/2022	244,769	8,465	15,674	29,182	N/A
9/30/2022	258,221	20,210	11,222	33,894	N/A
6/30/2022	271,469	19,347	5,999	30,060	N/A
3/31/2022	252,923	13,718	-11,426	12,870	N/A
12/31/2021	231,510	9,992	-19,195	6,843	N/A
9/30/2021	206,908	-3,656	-31,182	-9,067	N/A
6/30/2021	215,880	-9,767	-29,798	-4,289	N/A
3/31/2021	210,944	-11,040	-31,286	-2,772	N/A
12/31/2020	215,486	-8,915	-22,217	3,346	N/A
9/30/2020	219,591	-7,599	-2,581	20,218	N/A
6/30/2020	197,237	-674	492	19,212	N/A
3/31/2020	222,509	8,020	17,885	32,000	N/A
12/31/2019	217,056	6,258	12,366	26,055	N/A
9/30/2019	208,589	3,251	5,841	23,414	N/A
6/30/2019	197,351	-1,694	82	14,707	N/A
3/31/2019	165,826	-2,744	-15,795	789	N/A
12/31/2018	165,400	683	-15,331	2,907	N/A
9/30/2018	166,900	-13,246	-15,981	1,126	N/A
6/30/2018	168,540	-11,447	N/A	9,864	N/A
3/31/2018	184,008	-12,010	N/A	23,944	N/A
12/31/2017	181,187	-13,853	N/A	22,462	N/A
9/30/2017	179,097	108	N/A	24,745	N/A
6/30/2017	183,925	878	N/A	25,274	N/A
3/31/2017	164,403	-1,808	N/A	13,599	N/A
12/31/2016	155,022	-4,199	N/A	11,329	N/A
9/30/2016	150,250	-17,783	N/A	10,815	N/A
6/30/2016	142,324	-23,624	N/A	555	N/A
3/31/2016	161,802	-29,546	N/A	-5,335	N/A
12/31/2015	197,145	-34,490	N/A	7,121	N/A
9/30/2015	265,999	-19,076	N/A	-3,850	N/A
6/30/2015	338,575	-12,616	N/A	24,086	N/A
3/31/2015	376,412	-12,445	N/A	25,080	N/A
12/31/2014	402,102	-5,818	N/A	12,044	N/A
9/30/2014	403,845	3,556	N/A	24,304	N/A
6/30/2014	396,569	-1,117	N/A	-4,585	N/A
3/31/2014	403,785	3,974	N/A	3,115	N/A
12/31/2013	420,460	5,583	N/A	7,660	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei A025320 ( 27.5% per jaar) ligt boven de spaarquote ( 2.7% ).

Winst versus markt: De winst van A025320 ( 27.5% per jaar) zal naar verwachting langzamer groeien dan de markt KR ( 28% per jaar).

Hoge groeiwinsten: De winst van A025320 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van A025320 ( 16.3% per jaar) zal naar verwachting sneller groeien dan de markt KR ( 9.4% per jaar).

Hoge groei-inkomsten: De omzet van A025320 ( 16.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen A025320 zal naar verwachting over 3 jaar laag zijn ( 16.8 %).

Synopex Toekomstige groei

Future criteriumcontroles 3/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Third quarter 2024 earnings released: EPS: ₩17.00 (vs ₩36.00 in 3Q 2023)

Is Now The Time To Look At Buying Synopex Inc. (KOSDAQ:025320)?

Investor sentiment deteriorates as stock falls 21%

Returns At Synopex (KOSDAQ:025320) Are On The Way Up

New major risk - Financial data availability

Risks Still Elevated At These Prices As Synopex Inc. (KOSDAQ:025320) Shares Dive 25%

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 18%

Now 23% overvalued after recent price rise

There's Reason For Concern Over Synopex Inc.'s (KOSDAQ:025320) Massive 26% Price Jump

Now 41% overvalued after recent price rise

Investor sentiment improves as stock rises 22%

Now 22% overvalued after recent price rise

Now 21% overvalued after recent price rise

Synopex (KOSDAQ:025320) Seems To Use Debt Rather Sparingly

What Synopex Inc.'s (KOSDAQ:025320) 29% Share Price Gain Is Not Telling You

Investor sentiment improves as stock rises 25%

Why Synopex Inc. (KOSDAQ:025320) Could Be Worth Watching

Investor sentiment deteriorates as stock falls 15%

Synopex's (KOSDAQ:025320) Performance Is Even Better Than Its Earnings Suggest

Full year 2023 earnings released: EPS: ₩180 (vs ₩108 in FY 2022)

Market Participants Recognise Synopex Inc.'s (KOSDAQ:025320) Revenues Pushing Shares 55% Higher

Now 21% undervalued

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 24%

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

Full year 2022 earnings released: EPS: ₩117 (vs ₩138 in FY 2021)

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

New 90-day low: ₩3,930

Synopex Inc. announced that it has received KRW 15 billion in funding from Eugene Private Equity, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm

Synopex Inc. announced that it expects to receive KRW 15 billion in funding from Eugene Private Equity, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, and other investors

Here's Why Synopex (KOSDAQ:025320) Can Afford Some Debt

New 90-day low: ₩3,945

Synopex (KOSDAQ:025320) Shareholders Have Enjoyed An Impressive 227% Share Price Gain

New 90-day low: ₩4,115

New 90-day high - ₩5,500

Synopex Inc. (KOSDAQ:A025320) agreed to acquire 66.67% stake in Flontec Co., Ltd. from Noksan Trading Co., Ltd. and others for KRW 1.3 billion.

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven